FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models-Reference-Cited by-同舟云学术

FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models

Published:2020-03 Issue: Volume:325 Page:113120
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Vidal-Martinez Guadalupe,Segura-Ulate Ismael,Yang Barbara,Diaz-Pacheco Valeria,Barragan Jose A.,De-Leon Esquivel Jocelyn,Chaparro Stephanie A.,Vargas-Medrano Javier,Perez Ruth G.

Funder

Fogarty International Center

Texas Tech University Health Sciences Center El Paso Graduate School of Biomedical Sciences

Multiple System Atrophy Coalition

Lizanell and Colbert Coldwell Foundation

El Paso Community Foundation

Paso Del Norte Health Foundation

Hoy Family Research

Perez Family Research

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference101 articles.

1. Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease;Ahmed;Brain Pathol.,2013

2. The vulnerable ventral tegmental area in Parkinson's disease;Alberico;Basal Ganglia,2015

3. Large-scale mitochondrial DNA deletion underlying familial multiple system atrophy of the cerebellar subtype;Alsemari;Clin. Case Rep.,2015

4. Bleach gel: a simple agarose gel for analyzing RNA quality;Aranda;Electrophoresis,2012

5. Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions and special considerations;Ayzenberg;Ther. Clin. Risk Manag.,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Validation of FTY720 and FTY720-Mitoxy in Mouse Models of Parkinsons Disease and Multiple System Atrophy (MSA): Evidence for Treating Lewy Body Disease Synucleinopathies Including MSA;Rare Neurodegenerative Disorders - New Insights [Working Title];2024-05-23

2. The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases;Current Topics in Medicinal Chemistry;2024-04-26

3. Recent Advances in Clinical Trials in Multiple System Atrophy;Current Neurology and Neuroscience Reports;2024-02-28

4. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model;Acta Pharmacologica Sinica;2023-08-21

5. Inflammation in multiple system atrophy;Frontiers in Immunology;2023-06-22